enGene Therapeutics Inc. (ENGN) ROA
- 2026-04-30: ROA -41.25%.
- 2026-01-31: ROA -36.32%.
- 2025-10-31: ROA -52.97%.
- 2025-07-31: ROA -38.58%.
Complete source-backed roa history.
- Available history
- 2022-10-31 to 2026-04-30
- Data captured
Historical ROA
| Date | ROA |
|---|
| 2026-04-30 | -41.25% |
|---|
| 2026-01-31 | -36.32% |
|---|
| 2025-10-31 | -52.97% |
|---|
| 2025-07-31 | -38.58% |
|---|
| 2025-04-30 | -29.96% |
|---|
| 2025-01-31 | -24.15% |
|---|
| 2024-10-31 | -17.72% |
|---|
| 2024-07-31 | -45.84% |
|---|
| 2024-04-30 | -41.28% |
|---|
| 2024-01-31 | -110.48% |
|---|
| 2023-10-31 | -114.90% |
|---|
Annual ROA
| Date | ROA |
|---|
| 2025-10-31 | -52.97% |
|---|
| 2024-10-31 | -17.72% |
|---|
| 2023-10-31 | -114.90% |
|---|
| 2022-10-31 | -102.31% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
|---|
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
|---|
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
|---|
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
|---|